Back to search
Moderate to Severe Ulcerative Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Ulcerative Colitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Ulcerative Colitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Crohn s disease (CD) is an inflammatory bowel disease. It causes inflammation of the gut. Symptoms may include diarrhea, abdominal pain, fatigue, w…
The aim of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of filgotinib as a treatment for UC in children and adolescen…
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and sev…
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (C…
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderately to severe…
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the…
The study is being conducted to evaluate the safety, tolerability and pharmakokinetics of HRS-7085 in adults.
This Phase I first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-7590 via subcutaneous or intravenous adm…